Form D · Other Health Care
Hera Diagnostics Corp
Mcallen, TX · CIK 0001880574
Offering snapshot reported Dec 5, 2022 · SEC filing
- Reported sold
- $898K Offering amount: $3.66M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 5, 2022 | Initial | $898,306 | No comparison | 7 | SEC filing |
| Sep 15, 2021 | Initial | $0 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-466487
Total amount sold includes conversion of convertible promissory notes
Source: Form D, filed Dec 5, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Delaney Dunn Dichoso | Director |
| Hector De Jesus Ruiz | Director |
| Jesus Seanez | Director |
| Teofilo Tijerina | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2124 South 34 Th St.
Mcallen, TX, 78503
Mcallen, TX, 78503